ID: ALA5199708

Max Phase: Preclinical

Molecular Formula: C33H49NO9

Molecular Weight: 603.75

Associated Items:

Representations

Canonical SMILES:  CC(/C=C/[C@H]1O[C@H](CC(=O)OC2CC2)C[C@@]2(CO2)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)C(C)C)C[C@@H]1C

Standard InChI:  InChI=1S/C33H49NO9/c1-19(2)32(38)40-22(5)9-14-29(35)34-26-15-21(4)27(41-23(26)6)12-7-20(3)8-13-28-31(37)33(18-39-33)17-25(42-28)16-30(36)43-24-10-11-24/h7-9,13-14,19,21-28,31,37H,10-12,15-18H2,1-6H3,(H,34,35)/b13-8+,14-9-,20-7+/t21-,22-,23+,25+,26+,27-,28+,31+,33+/m0/s1

Standard InChI Key:  FVIISXRQJKQRGO-NFUAKRLWSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 603.75Molecular Weight (Monoisotopic): 603.3407AlogP: 3.70#Rotatable Bonds: 12
Polar Surface Area: 132.92Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.92CX Basic pKa: CX LogP: 3.43CX LogD: 3.43
Aromatic Rings: 0Heavy Atoms: 43QED Weighted: 0.15Np Likeness Score: 2.21

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source